These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24613849

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Utility of chromosomal chromogenic in situ hybridization as an alternative to flow cytometry and cytogenetics in the diagnosis of early partial hydatidiform moles: a validation study.
    Folkins A, Cruz L, Goldstein DP, Berkowitz RS, Crum C, Kindelberger D.
    J Reprod Med; 2010; 55(7-8):275-8. PubMed ID: 20795338
    [Abstract] [Full Text] [Related]

  • 24. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
    Dong Y, Zhang S, Wang ML, Guo H, Zhang Y, Wang Y, Li T.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr 18; 43(2):194-8. PubMed ID: 21503111
    [Abstract] [Full Text] [Related]

  • 25. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization.
    Chiang S, Fazlollahi L, Nguyen A, Betensky RA, Roberts DJ, Iafrate AJ.
    J Mol Diagn; 2011 Jul 18; 13(4):406-15. PubMed ID: 21704275
    [Abstract] [Full Text] [Related]

  • 26. p57KIP2 immunostaining in the diagnosis of complete versus partial hydatidiform moles.
    Sebire NJ, Lindsay I.
    Histopathology; 2006 Jun 18; 48(7):873-4. PubMed ID: 16722940
    [No Abstract] [Full Text] [Related]

  • 27. Diandric triploid hydatidiform mole with loss of maternal chromosome 11.
    DeScipio C, Haley L, Beierl K, Pandit AP, Murphy KM, Ronnett BM.
    Am J Surg Pathol; 2011 Oct 18; 35(10):1586-91. PubMed ID: 21881485
    [Abstract] [Full Text] [Related]

  • 28. A case of complete hydatidiform mole in a perimenopausal woman with diagnostic usefulness of p57(kip2) immunohistochemistry and HER2 fluorescent in situ hybridization.
    Hatanaka K, Higashi M, Fujibayashi M, Hori S, Yoshioka T, Umekita Y, Tanimoto A.
    Pathol Res Pract; 2012 Feb 15; 208(2):118-20. PubMed ID: 22197173
    [Abstract] [Full Text] [Related]

  • 29. Hydatidiform moles: ancillary techniques to refine diagnosis.
    Ronnett BM, DeScipio C, Murphy KM.
    Int J Gynecol Pathol; 2011 Mar 15; 30(2):101-16. PubMed ID: 21293291
    [Abstract] [Full Text] [Related]

  • 30. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of Hydatidiform Mole and Hydropic Abortion.
    Maggiori MS, Peres LC.
    Eur J Obstet Gynecol Reprod Biol; 2007 Dec 15; 135(2):170-6. PubMed ID: 17602823
    [Abstract] [Full Text] [Related]

  • 31. [Expression of p57 marker in differential diagnosis of complete and partial mole - correlation with DNA analysis].
    Cierna Z, Palkovič M, Danihel Ml L, Danihel L, Repiská V, Vojtaššák J, Korbeľ M.
    Cesk Patol; 2012 Oct 15; 48(4):218-21. PubMed ID: 23121032
    [Abstract] [Full Text] [Related]

  • 32. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles.
    Brown L, Mount S, Reddy R, Slim R, Wong C, Jobanputra V, Clifford P, Merrill L, Brown S.
    Int J Gynecol Pathol; 2013 Jul 15; 32(4):399-405. PubMed ID: 23722513
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Expression of p57Kip2 and its significance in the classification and differential diagnosis of hydatidiform moles and hydropic abortions].
    He Y, Yang KX, Wang HJ, Xu L, Huang Q, Wu XL.
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar 15; 36(3):197-9. PubMed ID: 17535690
    [No Abstract] [Full Text] [Related]

  • 35. Accuracy of p57KIP2 compared with genotyping for the diagnosis of complete hydatidiform mole: protocol for a systematic review and meta-analysis.
    Madi JM, Braga AR, Paganella MP, Litvin IE, Da Ros Wendland EM.
    Syst Rev; 2016 Oct 04; 5(1):169. PubMed ID: 27716354
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.
    Xing D, Adams E, Huang J, Ronnett BM.
    Mod Pathol; 2021 May 04; 34(5):961-982. PubMed ID: 33024305
    [Abstract] [Full Text] [Related]

  • 39. [Diagnostic utility of STR genotyping for partial hydatidiform moles].
    Chang B, Lu L, Zheng X, Qin X.
    Zhonghua Bing Li Xue Za Zhi; 2015 Dec 04; 44(12):868-73. PubMed ID: 26888503
    [Abstract] [Full Text] [Related]

  • 40. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
    Lai CY, Chan KY, Khoo US, Ngan HY, Xue WC, Chiu PM, Tsao SW, Cheung AN.
    Mod Pathol; 2004 Jan 04; 17(1):40-8. PubMed ID: 14631372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.